Rapport Therapeutics, Inc. — All Filings
173 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
3
4
424B4
424B5
8-A12B
8-K
ARS
CERT
CORRESP
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
S-1
S-1/A
S-3
S-3ASR
S-8
SC 13D
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 4 | 4 | 0001839046-25-000004 | Sep 10, 2025 | Sep 8, 2025 |
| 424B5 | 424B5 | 0001193125-25-198453 | Sep 8, 2025 | — |
| 144 | — | 0001950047-25-006846 | Sep 8, 2025 | — |
| 8-K | 8-K | 0001193125-25-198322 | Sep 8, 2025 | — |
| 8-K | 8-K | 0001193125-25-197610 | Sep 8, 2025 | — |
| 4 | 4 | 0000950170-25-109838 | Aug 18, 2025 | Aug 15, 2025 |
| 10-Q | 10-Q | 0000950170-25-104565 | Aug 7, 2025 | Jun 30, 2025 |
| 8-K | 8-K | 0000950170-25-104557 | Aug 7, 2025 | — |
| 4 | 4 | 0000950170-25-096268 | Jul 16, 2025 | Jul 15, 2025 |
| EFFECT | — | 9999999995-25-002211 | Jul 9, 2025 | — |
| EFFECT | — | 9999999995-25-002210 | Jul 9, 2025 | — |
| CORRESP | — | 0001193125-25-156166 | Jul 7, 2025 | — |
| CORRESP | — | 0001193125-25-156162 | Jul 7, 2025 | — |
| UPLOAD | — | 0000000000-25-007103 | Jul 7, 2025 | — |
| UPLOAD | — | 0000000000-25-007101 | Jul 7, 2025 | — |
| S-3 | S-3 | 0001193125-25-153417 | Jul 1, 2025 | — |
| S-3 | S-3 | 0001193125-25-153415 | Jul 1, 2025 | — |
| 8-K | 8-K | 0000950170-25-087921 | Jun 18, 2025 | Jun 17, 2025 |
| 4 | 4 | 0000950170-25-087904 | Jun 18, 2025 | Jun 17, 2025 |
| 4 | 4 | 0000950170-25-087903 | Jun 18, 2025 | Jun 17, 2025 |
| 4 | 4 | 0000950170-25-087902 | Jun 18, 2025 | Jun 17, 2025 |
| 4 | 4 | 0000950170-25-087901 | Jun 18, 2025 | Jun 17, 2025 |
| 4 | 4 | 0000950170-25-087900 | Jun 18, 2025 | Jun 17, 2025 |
| 4 | 4 | 0000950170-25-087899 | Jun 18, 2025 | Jun 17, 2025 |
| 4 | 4 | 0000950170-25-087898 | Jun 18, 2025 | Jun 17, 2025 |
| 4 | 4 | 0000950170-25-087897 | Jun 18, 2025 | Jun 16, 2025 |
| 4 | 4 | 0000950170-25-087896 | Jun 18, 2025 | Jun 17, 2025 |
| 144 | — | 0001950047-25-004362 | Jun 16, 2025 | — |
| 8-K | 8-K | 0000950170-25-080247 | Jun 2, 2025 | — |
| 4 | 4 | 0000950170-25-074409 | May 19, 2025 | May 15, 2025 |
| 10-Q | 10-Q | 0000950170-25-066393 | May 8, 2025 | Mar 31, 2025 |
| 8-K | 8-K | 0000950170-25-066376 | May 8, 2025 | — |
| ARS | ARS | 0001193125-25-092144 | Apr 24, 2025 | Dec 31, 2024 |
| DEFA14A | DEFA14A | 0001193125-25-092139 | Apr 24, 2025 | — |
| DEF 14A | DEF 14A | 0001193125-25-092133 | Apr 24, 2025 | Jun 17, 2025 |
| 4 | 4 | 0000950170-25-054819 | Apr 16, 2025 | Apr 15, 2025 |
| 4 | 4 | 0000950170-25-050557 | Apr 3, 2025 | Apr 1, 2025 |
| 4 | 4 | 0000950170-25-040447 | Mar 17, 2025 | Mar 14, 2025 |
| 144 | — | 0001950047-25-001860 | Mar 14, 2025 | — |
| 4 | 4 | 0000950170-25-038878 | Mar 13, 2025 | Mar 12, 2025 |
| 4 | 4 | 0000950170-25-038855 | Mar 13, 2025 | Mar 12, 2025 |
| S-8 | S-8 | 0000950170-25-036832 | Mar 11, 2025 | — |
| 10-K | 10-K | 0000950170-25-036828 | Mar 11, 2025 | Dec 31, 2024 |
| 8-K | 8-K | 0000950170-25-036822 | Mar 11, 2025 | — |
| 4 | 4 | 0000950170-25-033797 | Mar 5, 2025 | Mar 3, 2025 |
| 3 | 3 | 0000950170-25-033796 | Mar 5, 2025 | Mar 3, 2025 |
| 8-K | 8-K | 0001193125-25-043405 | Mar 3, 2025 | — |
| SCHEDULE 13G | — | 0000950170-25-019904 | Feb 13, 2025 | — |
| 4 | 4 | 0000950170-25-013754 | Feb 4, 2025 | Feb 3, 2025 |
| 4 | 4 | 0000950170-25-013753 | Feb 4, 2025 | Feb 3, 2025 |